Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
Dianthus Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 21, 2021
Dianthus Therapeutics reported fiscal year 2020 executive compensation information on April 21, 2021.
In 2020, three executives at Dianthus Therapeutics received on average a compensation package of $2.3M, a 77% increase compared to previous year.
Average pay of disclosed executives at Dianthus Therapeutics
Jason Gardner, Chief Executive Officer, received $3.1M in total, which increased by 88% compared to 2019. 74% of Gardner's compensation, or $2.3M, was in option awards. Gardner also received $262K in non-equity incentive plan, $530K in salary, as well as $1.3K in other compensation.
Stephen F. Mahoney, Chief Financial and Operating Officer, received a compensation package of $2M. 96% of the compensation package, or $1.9M, was in option awards.
John C. Davis, Jr., Chief Medical Officer, earned $1.8M in 2020, a 93% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2021.